CMIC

Executive Summary

CMIC is a private contract research organization (CRO) founded in 2002, headquartered in New York, with a strong presence across the US, Japan, and Asia. The company provides trusted drug discovery and clinical research services to pharmaceutical and biotechnology clients, leveraging its global footprint to facilitate cross-border clinical trials and regulatory submissions. With a focus on pre-clinical and early-stage development, CMIC aims to accelerate drug development timelines by offering integrated service solutions tailored to both Western and Asian markets. The company's long-standing experience and established infrastructure position it as a reliable partner for clients seeking to expand their clinical operations into Asia while maintaining high quality standards.

Upcoming Catalysts (preview)

• Q4 2026Expansion of service offerings into cell and gene therapy50% success
• Q2 2027Strategic partnership with a top 20 pharma company for Asian trials30% success
• 2027Potential acquisition by a larger CRO seeking Asian presence25% success